# FOXJ2

## Overview
FOXJ2 is a gene that encodes the forkhead box J2 protein, a member of the forkhead family of transcription factors. This protein is characterized by a conserved forkhead domain that facilitates its binding to specific DNA sequences, thereby regulating the transcription of genes involved in critical cellular processes such as proliferation, differentiation, and survival (QIANG2015Abnormal). The FOXJ2 protein is predominantly localized in the nucleus, where it functions as a transcriptional activator, influencing genes that are essential for maintaining cellular homeostasis and organismal development (Bai2022Germline). Its expression is widespread across various tissues, underscoring its importance in diverse biological functions (MartíndeLara2008Biological). Additionally, FOXJ2 has been implicated in pathological conditions, including cancer, where its altered expression can affect tumor progression and patient prognosis (ZHANG2016The).

## Function
FOXJ2 is a transcription factor that plays a significant role in regulating various cellular processes in healthy human cells. It is involved in transcriptional regulation by binding to specific DNA sequences through its conserved forkhead domain, influencing the expression of genes related to cell proliferation, differentiation, and survival (QIANG2015Abnormal). FOXJ2 is widely expressed across different organs and tissues, indicating its broad functional importance in maintaining normal cellular functions and organismal homeostasis (MartíndeLara2008Biological).

In cell biology, FOXJ2 is implicated in regulating genes that affect cell adhesion and migration, such as E-cadherin, which is crucial for maintaining epithelial characteristics and suppressing mesenchymal transition (QIANG2015Abnormal). This regulation is vital for processes like embryogenesis and wound healing. FOXJ2's activity is primarily localized in the nucleus, where it acts as a transcriptional activator, modulating the expression of target genes involved in essential cellular processes (Bai2022Germline).

The protein's role extends to influencing the cell cycle and cellular proliferation, as evidenced by its increased expression in proliferating astrocytes during spinal cord injury (QIANG2015Abnormal). Overall, FOXJ2 contributes to the regulation of essential cellular processes and the maintenance of normal physiological functions in the human body.

## Clinical Significance
Alterations in the expression of the FOXJ2 gene have been implicated in several diseases, particularly cancers. In extrahepatic cholangiocarcinoma (CC), FOXJ2 expression is significantly downregulated in cancerous tissues compared to normal bile duct tissues. This downregulation is associated with disease progression, including lymphatic invasion and lymph node metastasis. Patients with lower FOXJ2 expression levels have shorter postoperative survival, suggesting that FOXJ2 acts as a tumor suppressor in this type of cancer. Overexpression of FOXJ2 has been shown to inhibit cell proliferation, migration, and invasion, indicating its potential as a therapeutic target and prognostic marker for extrahepatic CC (QIANG2015Abnormal).

In hepatocellular carcinoma (HCC), FOXJ2 is also downregulated, and its low expression correlates with poorer survival outcomes, larger tumor size, and increased metastasis. High FOXJ2 expression is linked to improved patient survival, suggesting its role as a prognostic marker. Silencing FOXJ2 promotes cell proliferation, further supporting its function as a tumor suppressor in HCC (ZHANG2016The).

Additionally, elevated serum antibodies against FOXJ2 have been identified as potential biomarkers for acute ischemic stroke and other conditions, indicating its involvement in inflammatory and autoimmune diseases (Hiwasa2021Serum).

## Interactions
FOXJ2, a transcription factor, is known to interact with specific DNA sequences, influencing gene expression. It binds to the promoter regions of genes such as E-cadherin (CDH1) and Connexin-43 (Cx-43), which are involved in cell adhesion and gap junction formation, respectively. This binding has been demonstrated through chromatin immunoprecipitation (ChIP) assays and electrophoretic mobility shift assays (EMSAs), indicating FOXJ2's role in regulating these genes' transcriptional activity (Zhang2018ARHGAP9; MartíndeLara2008Biological).

In hepatocellular carcinoma (HCC) cells, FOXJ2 enhances the transcription of E-cadherin by binding to its promoter, a process that is modulated by ARHGAP9. Overexpression of ARHGAP9 increases FOXJ2's binding to the E-cadherin promoter, thereby promoting E-cadherin expression and inhibiting cancer cell migration and invasion (Zhang2018ARHGAP9).

In lung cancer cells, FOXJ2 is involved in cholesterol metabolism regulation. It binds to the promoters of cholesterol synthesis genes such as HMGCR, HMGCS1, and IDI1, particularly upon STAT6 silencing, which leads to increased FOXJ2 expression and activity (Dubey2015STAT6). These interactions highlight FOXJ2's role in various cellular processes through its binding to specific nucleic acid sequences.


## References


[1. (ZHANG2016The) ZHONGBAO ZHANG, GUANGJU MENG, LIANG WANG, YINGYING MA, and ZHONGZHENG GUAN. The prognostic role and reduced expression of foxj2 in human hepatocellular carcinoma. Molecular Medicine Reports, 14(1):254–262, May 2016. URL: http://dx.doi.org/10.3892/mmr.2016.5261, doi:10.3892/mmr.2016.5261. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2016.5261)

[2. (Bai2022Germline) Fu-Rong Bai, Qi-Qian Wu, Yu-Jie Wu, Yan-Qin Hu, Zhi-Xuan Jiang, Hao Lv, Wen-Zhe Qian, Chang Cai, and Jing-Wen Wu. Germline foxj2 overexpression causes male infertility via aberrant autophagy activation by lamp2a upregulation. Cell Death &amp; Disease, July 2022. URL: http://dx.doi.org/10.1038/s41419-022-05116-w, doi:10.1038/s41419-022-05116-w. This article has 8 citations.](https://doi.org/10.1038/s41419-022-05116-w)

[3. (Hiwasa2021Serum) Takaki Hiwasa, Hao Wang, Ken-ichiro Goto, Seiichiro Mine, Toshio Machida, Eiichi Kobayashi, Yoichi Yoshida, Akihiko Adachi, Tomoo Matsutani, Mizuki Sata, Kazumasa Yamagishi, Hiroyasu Iso, Norie Sawada, Shoichiro Tsugane, Mitoshi Kunimatsu, Ikuo Kamitsukasa, Masahiro Mori, Kazuo Sugimoto, Akiyuki Uzawa, Mayumi Muto, Satoshi Kuwabara, Yoshio Kobayashi, Mikiko Ohno, Eiichiro Nishi, Akiko Hattori, Masashi Yamamoto, Yoshiro Maezawa, Kazuki Kobayashi, Ryoichi Ishibashi, Minoru Takemoto, Koutaro Yokote, Hirotaka Takizawa, Takashi Kishimoto, Kazuyuki Matsushita, Sohei Kobayashi, Fumio Nomura, Takahiro Arasawa, Akiko Kagaya, Tetsuro Maruyama, Hisahiro Matsubara, Minako Tomiita, Shinsaku Hamanaka, Yushi Imai, Tomoo Nakagawa, Naoya Kato, Jiro Terada, Takuma Matsumura, Yusuke Katsumata, Akira Naito, Nobuhiro Tanabe, Seiichiro Sakao, Koichiro Tatsumi, Masaaki Ito, Fumiaki Shiratori, Makoto Sumazaki, Satoshi Yajima, Hideaki Shimada, Mikako Shirouzu, Shigeyuki Yokoyama, Takashi Kudo, Hirofumi Doi, Katsuro Iwase, Hiromi Ashino, Shu-Yang Li, Masaaki Kubota, Go Tomiyoshi, Natsuko Shinmen, Rika Nakamura, Hideyuki Kuroda, and Yasuo Iwadate. Serum anti-dido1, anti-cpsf2, and anti-foxj2 antibodies as predictive risk markers for acute ischemic stroke. BMC Medicine, June 2021. URL: http://dx.doi.org/10.1186/s12916-021-02001-9, doi:10.1186/s12916-021-02001-9. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s12916-021-02001-9)

[4. (Dubey2015STAT6) Richa Dubey and Neeru Saini. Stat6 silencing up-regulates cholesterol synthesis via mir-197/foxj2 axis and induces er stress-mediated apoptosis in lung cancer cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1849(1):32–43, January 2015. URL: http://dx.doi.org/10.1016/j.bbagrm.2014.10.002, doi:10.1016/j.bbagrm.2014.10.002. This article has 20 citations.](https://doi.org/10.1016/j.bbagrm.2014.10.002)

[5. (Zhang2018ARHGAP9) Hong Zhang, Qing-Feng Tang, Meng-Yao Sun, Chun-Yan Zhang, Jian-Yong Zhu, Yu-Li Shen, Bin Zhao, Zhi-Yi Shao, Li-Jun Zhang, and Hong Zhang. Arhgap9 suppresses the migration and invasion of hepatocellular carcinoma cells through up-regulating foxj2/e-cadherin. Cell Death &amp; Disease, September 2018. URL: http://dx.doi.org/10.1038/s41419-018-0976-0, doi:10.1038/s41419-018-0976-0. This article has 24 citations.](https://doi.org/10.1038/s41419-018-0976-0)

[6. (MartíndeLara2008Biological) F. Martín-de-Lara, P. Sánchez-Aparicio, Carmen Arias de la Fuente, and J. Rey-Campos. Biological effects of foxj2 over-expression. Transgenic Research, 17(6):1131–1141, August 2008. URL: http://dx.doi.org/10.1007/s11248-008-9214-3, doi:10.1007/s11248-008-9214-3. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11248-008-9214-3)

[7. (QIANG2015Abnormal) YONG QIANG, FEIRAN WANG, SUJUAN YAN, HAITAO ZHANG, LIRONG ZHU, ZHEN CHEN, FANG TU, DONGZHI WANG, GANG WANG, WEI WANG, and ZHONG CHEN. Abnormal expression of forkhead box j2 (foxj2) suppresses migration and invasion in extrahepatic cholangiocarcinoma and is associated with prognosis. International Journal of Oncology, 46(6):2449–2458, April 2015. URL: http://dx.doi.org/10.3892/ijo.2015.2957, doi:10.3892/ijo.2015.2957. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijo.2015.2957)